Sorafenib/piroxicam therapy with biomarker-defined survival benefit in canine muscle-invasive urothelial carcinoma - Shingo Maeda; Shohei Yokota; Mao Komori; Yuko Goto-Koshino; James K. Chambers; Kazuyuki Uchida; Tomohiro Yonezawa; Yasuyuki Momoi (Scientific Reports, 2026)